Eisai and Fronteo to Launch Coroban Tumbling and Falling Prediction System for Inpatients

Sep 26, 2019 14:08 JST

Source: Eisai

TOKYO, Sep 26, 2019 - (JCN Newswire) - Eisai Co., Ltd. and FRONTEO, Inc. announced today that they have launched the tumbling and falling prediction system Coroban to medical institutions in Japan on September 26, 2019. The Coroban predicts inpatients' tumbling and falling risks in advance and displays alerts.

Through the launch of antiosteoporotic agent and insomnia treatment, a pharmaceutical company Eisai has recognized that the preventive measures for tumbling and falling at medical institutions are important. On the other hand, FRONTEO Healthcare, Inc., a wholly owned subsidiary of FRONTEO, is a data analysis corporation focused on healthcare. It has originally developed an artificial intelligence (AI) system called Concept Encoder based on natural language processing technique.

Eisai and FRONTEO have started the joint development for the Coroban since January 2018. The Coroban was introduced to several medical institutions in Japan on a trial basis by leveraging Eisai's network with medical institutions, and advancing the improvements of Coroban based on needs in the clinical settings has led to the launch of the Coroban this time.

According to a survey by the Ministry of Health, Labour and Welfare, the number of inpatients aged 65 and over tends to increase to about 960,000 in 2017, therefore, the importance of cares for tumbling and falling in medical institutions is increasing. The Coroban learns the nursing records of past inpatients at each medical institution, scores the tumbling and falling risks of individual inpatient from the daily nursing records based on these past records, and displays the information of inpatients with high risks. It is expected to reduce the burden of medical professionals and to make the risk assessment uniform and objective by reflecting the information in individual care and nursing plans for each patient's tumbling and falling with the Coroban.

Through the launch of the Coroban which supports to establish systems at nursing ward to reduce the tumbling and falling risks of inpatients, Eisai and Fronteo aim to contribute to the realization of well-being of patients and their families.

About the tumbling and falling prediction system Coroban

Product name: Tumbling and Falling Prediction System Coroban
* The Coroban is not a medical device.

About Concept Encoder AI system

Concept Encoder is the AI system developed by FRONTEO Healthcare. Inc. specifically for the healthcare industry. The system was developed with the aim of effective, evidence-based analysis and utilization of healthcare-related big data, including large bodies of free-entry text data. The program incorporates significance tests and other crucial statistical methods for evidence-based medicine (EBM), the gold standard of practice among healthcare professionals, and applies this to natural language analysis. For more information, visit https://www.fronteo- healthcare.com/conceptencoder.

About FRONTEO, Inc. and FRONTEO Healthcare, Inc.

FRONTEO, Inc. supports the analysis of big data based on behavior informatics by utilizing its originally developed AI technology, "KIBIT". FRONTEO was found in 2003, and has ever since been developing our business primarily in the field of LegalTech including "eDiscovery" (preserve, process review, and analyze electronically stored data that could be evidence doe litigation process) and "digital forensics", as well as initiatives "Securely Identify Risks and Opportunities Buried in Records" in the field of business intelligence. FRONTEO Healthcare, Inc. was found in 2015. Through its data analysis capability, FRONTEO Healthcare, Inc. hopes to support people around the world in receiving the best healthcare services and pave the way to a healthier, more secure future.

For more information about FRONTEO, Inc. and FRONTEO Healthcare, Inc., please visit http://www.fronteo.com/ http://www.fronteo-healthcare.com/

Contact:

Media Inquiries:
Eisai Co., Ltd.
Public Relations Department 
TEL: +81-(0)3-3817-5120

Source: Eisai
Sectors: BioTech

Related Press Release

Eisai to Launch "Pariet S," the First Proton Pump Inhibitor RX-to-OTC in Japan

June 02 2025 16:46 JST

New Drug Approval for In-House Developed Anti-Insomnia Drug DAYVIGO (Lemborexant) in China

May 28 2025 16:45 JST

Eisai Demonstrates Commitment to Oncology Innovation at ASCO 2025

May 21 2025 14:00 JST

Eisai Satisfies All-Case Surveillance Requirement for Anticancer Agent Remitoro

May 16 2025 16:21 JST

Eisai Representative Corporate Officer and CEO Haruo Naito Awarded the Order of the Rising Sun, Gold and Silver Star

April 30 2025 13:17 JST

Leqembi (lecanemab) is the First Medicine that Slows Progression of Early Alzheimer's Disease to be Authorized in the European Union

April 18 2025 15:52 JST

Eisai to Divest Rights for Pariet in China to Peak Pharma

April 01 2025 12:15 JST

World's First Early Alzheimer's Disease Treatment Developed in Japan LEQEMBI Receives Prime Minister's Award at the 12th Technology Management and Innovation Awards

March 25 2025 16:28 JST

Eisai Selected as a Nadeshiko Brand 2025 as a Listed Company Excelling in Promotion of Women in the Workplace

March 25 2025 11:21 JST

Eisai Recognized as "2025 Kenko Investment for Health" for the First Time and Certified as "Outstanding Organization Of Kenko Investment for Health Program (White 500)" for the Sixth Time

March 10 2025 19:24 JST

More Press release >>

Latest Press Release

DENSO Acquires Axia Vegetable Seeds to Realize Sustainable Agriculture
Jul 04, 2025 16:20 JST

MHIET Launches 450kW Gas Cogeneration System Capable of Hydrogen Co-Firing
Jul 04, 2025 15:13 JST

Yachiyo Engineering and NEC launch adaptation finance study in Indonesia to calculate the adaptation value of disaster prevention measures
Jul 04, 2025 13:25 JST

Fujitsu to implement store monitoring solution for METRO Inc. in Canada, enhancing operational efficiency and policy compliance
Jul 04, 2025 13:19 JST

Fujitsu to develop ETF trading platform based on TSE's CONNEQTOR and provide it to Australian Securities Exchange
Jul 03, 2025 11:14 JST

Mitsubishi Motors Launches the All-New Grandis for the European Market
Jul 02, 2025 12:10 JST

Valuufy partners with Mainichi Future Creation Lab, Supporting New Approaches to Business Sustainability
Jul 02, 2025 12:00 JST

Fujitsu launches solution to enhance customers' global supply chain resilience
Jul 02, 2025 11:32 JST

MHI Receives Order to Supply Four Circulating Water Pumps for Units 5 and 6 of Sanmen Nuclear Power Plant in China Under Collaboration with Dongfang Electric Machinery
Jul 02, 2025 11:30 JST

Multi-purpose Arena in Odaiba Aomi Area TOYOTA ARENA TOKYO Construction Completed
Jul 01, 2025 22:56 JST

1Finity, a Fujitsu company, commences operations and reveals brand identity
Jul 01, 2025 22:53 JST

MHI Thermal Systems Begins Field Test of Jointly Developed "Surplus Renewable Energy Absorption and Release System"
Jul 01, 2025 22:40 JST

Japan's Telecommunications Carriers Strengthen Disaster Response Through Collaborative Information Sharing
Jul 01, 2025 22:30 JST

JCB and Mandai Wildlife Group Deepen Partnership with exclusive discounts for JCB cardmembers
Jul 01, 2025 16:00 JST

Fujitsu provides Japan's first AI-powered cloud-based library search service
Jul 01, 2025 11:30 JST

JCB Brings Apple Pay to Cardmembers in Vietnam
Jul 01, 2025 11:15 JST

First Shipment of LNG from the LNG Canada Project
Jul 01, 2025 11:00 JST

Approval in Principle (AiP) for World's First LCO2 / Methanol Carrier
Jun 30, 2025 20:30 JST

Acropolis Rally Greece: Day 4 Sunday success and second overall for TOYOTA GAZOO Racing's Ogier
Jun 30, 2025 20:15 JST

Mitsubishi Fuso-Hino Merger: 4 Firms Collaborate for the Future of Commercial Vehicles
Jun 30, 2025 20:10 JST

More Latest Release >>